Literature DB >> 17933966

Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.

David C Isbell1, Szilard Voros, Zequan Yang, Joseph M DiMaria, Stuart S Berr, Brent A French, Frederick H Epstein, Sanford P Bishop, Hongkun Wang, Rene J Roy, Brandon A Kemp, Hiroaki Matsubara, Robert M Carey, Christopher M Kramer.   

Abstract

Angiotensin II type 2 receptor (AT(2)R) overexpression (AT(2)TG) attenuates left ventricular remodeling in a mouse model of anterior myocardial infarction (MI). We hypothesized that the beneficial effects of cardiac AT(2)TG are mediated via the bradykinin subtype 2 receptor (B(2)R). Fourteen transgenic mice overexpressing the AT(2)R (AT(2)TG mice), 10 mice with a B(2)R deletion (B(2)KO mice), 13 AT(2)TG mice with B(2)R deletion (AT(2)TG/B(2)KO mice), and 11 wild-type (WT) mice were studied. All mice were on a C57BL/6 background. Mice were studied by cardiac magnetic resonance imaging at baseline and days 1, 7, and 28 after MI induced by 1 h of occlusion of the left anterior descending artery followed by reperfusion. Short-axis images from apex to base were used to compare ventricular volumes and ejection fraction (EF). At baseline, end-diastolic volume index (EDVI) and end-systolic volume index (ESVI) were lower and EF higher in AT(2)TG mice compared with the other three strains. Infarct size was similar between groups. No differences were observed in global remodeling parameters at day 28 between AT(2)TG and AT(2)TG/B(2)KO mice; however, EDVI and ESVI were lower and EF higher in both transgenic groups than in WT or B(2)KO mice. Both strains lacking B(2)R demonstrated increased collagen content and less hypertrophy in adjacent noninfarcted regions at day 28. Attenuation of postinfarct remodeling by overexpression of AT(2)R is not directly mediated via a B(2)R pathway. However, B(2)R does appear to have a role in the smaller cavity size and hyperdynamic function observed at baseline in AT(2)TG mice and in limiting collagen deposition during postinfarct remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933966     DOI: 10.1152/ajpheart.00997.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Angiotensin II potentiates adrenergic and muscarinic modulation of guinea pig intracardiac neurons.

Authors:  Allison E Girasole; Christopher P Palmer; Samantha L Corrado; E Marie Southerland; Jeffrey L Ardell; Jean C Hardwick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-24       Impact factor: 3.619

2.  Smooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation.

Authors:  Tadashi Yoshida; Qiong Gan; Aaron S Franke; Ruoya Ho; Jifeng Zhang; Y Eugene Chen; Matsuhiko Hayashi; Mark W Majesky; Avril V Somlyo; Gary K Owens
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

Review 3.  AT2 receptors targeting cardiac protection post-myocardial infarction.

Authors:  Elena Kaschina; Dilyara Lauer; Patrick Schmerler; Thomas Unger; U Muscha Steckelings
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

4.  A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice.

Authors:  Alexander B Jehle; Yaqin Xu; Joseph M Dimaria; Brent A French; Frederick H Epstein; Stuart S Berr; Rene J Roy; Brandon A Kemp; Robert M Carey; Christopher M Kramer
Journal:  J Cardiovasc Pharmacol       Date:  2012-04       Impact factor: 3.105

5.  Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties.

Authors:  Mai E Shoman; Jenna F DuMond; T S Isbell; J H Crawford; Angela Brandon; Jaideep Honovar; Dario A Vitturi; C R White; R P Patel; S Bruce King
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

Review 6.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

7.  Dynamic remodeling of the guinea pig intrinsic cardiac plexus induced by chronic myocardial infarction.

Authors:  Jean C Hardwick; Shannon E Ryan; Eric Beaumont; Jeffrey L Ardell; E Marie Southerland
Journal:  Auton Neurosci       Date:  2013-10-31       Impact factor: 3.145

Review 8.  Anti-fibrotic Potential of AT2 Receptor Agonists.

Authors:  Yan Wang; Mark Del Borgo; Huey W Lee; Dhaniel Baraldi; Baydaa Hirmiz; Tracey A Gaspari; Kate M Denton; Marie-Isabel Aguilar; Chrishan S Samuel; Robert E Widdop
Journal:  Front Pharmacol       Date:  2017-08-31       Impact factor: 5.810

Review 9.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.